The Limited Times

Now you can see non-English news...

Germany buys new corona drug: It also helped Donald Trump - use even before EU approval?

2021-01-25T05:22:58.647Z

Germany has secured new antibody-based corona drugs. Health Minister Spahn confirmed the purchase. Karl Lauterbach (SPD) praised the investment.



Germany has secured new antibody-based corona drugs.

Health Minister Spahn confirmed the purchase.

Karl Lauterbach (SPD) praised the investment.

  • The federal government has bought new Corona * drugs for 400 million euros

  • Health Minister Jens Spahn confirmed the purchase.

    (see first report)

  • There are two substances from US manufacturers.

    They are not yet approved in the EU.

    (see update from January 24th, 8:08 pm)

Update from January 24th, 8:08 p.m.:

Health Minister

Jens Spahn

has raised hopes with the purchase of corona drugs (see first report).

In the meantime, more details about the treatment method that

is said to have helped

Donald Trump

are known.

The US FDA has already approved the drugs through an emergency procedure.

An assessment by the European authorities is still pending.

Corona antibody drug: Karl Lauterbach (SPD) praises Spahn's approach

The preparations can still be used in clinics.

The

Federal Ministry of Health (BMG) informed the dpa at the request of the dpa that the

application is based on an

individual risk-benefit assessment by the treating physicians

.

FDP health expert Andrew Ullman points out the need for further investigations.

The data situation is thin.

"If Spahn wants to approach the matter professionally, he has no choice but to test the drug as part of a study approval at university clinics."

According to BMG, two different monoclonal antibody-containing drugs were purchased from US manufacturers:

  • The antibody

    Bamlanivimab

    from Eli Lilly

  • and the simultaneously administered antibodies

    casirivimab and imdevimab from

    the manufacturer Regeneron

However, the

effect of the substances has

not yet been

finally proven

.

"According to the available studies, the medication could

possibly

help to limit the amount of virus in the body and thus have a positive influence on the course of the disease," a ministry spokesman explained the current state of research.

SPD health expert Karl Lauterbach

praised Spahn's approach.

The study situation indicates a

positive influence of

the medication, Lauterbach told the partner newspapers of the Neue Berliner Redaktionsgesellschaft (Monday edition).

“Because of the high cost of these drugs, the clinics would probably not have bought this supply.

So I welcome the action. "

Corona funds: Spahn announces purchase of new Covid drug

First report from January 24th, 9:58 am:

Berlin - The

corona

numbers in

Germany

are

slowly

falling

- probably thanks to the

lockdown

.

However, there is still great concern.

The new

mutations * of

the virus in

particular

recently ensured that the federal and state governments extended the applicable measures until mid-February - for the time being.

At the same time, the vaccination against corona is only starting slowly.

There is still too little vaccine * available.

Exactly at this point in time there is now a message that gives hope:

Germany has secured a new corona drug.

Health Minister

Jens Spahn has

now

confirmed

this to

Bild am Sonntag

.

Accordingly, it is the agent is a novel

drug to antibody

-

based

.

From next week, the monoclonal antibodies will be used in Germany as the first country in the EU.

Initially in university clinics, ”said Spahn about

BamS

.

In total, the federal government has bought 200,000 cans for 400 million euros.

Corona agent based on antibodies acts "like a passive vaccination"

"They work like a passive vaccination,"

said Spahn about the drug.

Accordingly, the antibody drug can especially help in the treatment of high-risk patients.

If they are administered in the early stages of an illness, the agent could help prevent a severe course of Covid, Spahn continued.

A similar corona agent probably also helped Donald Trump

According to media reports, the then US President

Donald Trump * was also

treated with this type of antibody after his corona infection.

Trump received the REGN-COV2 antibody cocktail from the US company Regeneron at the beginning of October.

The active ingredient of REGN-COV2 is a combination of two specially developed

antibodies

that bind to the so-called spike protein of the coronavirus and can thus deform its structure.

This is to prevent the coronavirus from attacking human cells.

According to Regeneron, the combination of two different antibodies should prevent the Sars-COV2 virus from mutating.

(rjs / af / dpa) * merkur.de is part of the nationwide Ippen digital editorial network.

List of rubric lists: © Matthias Balk / dpa

Source: merkur

All news articles on 2021-01-25

Similar news:

You may like

Trends 24h

News/Politics 2021-08-01T02:55:45.519Z

Latest

© Communities 2019 - Privacy